Roddy Walsh 🇪🇺 🇺🇦
banner
roddywalsh.bsky.social
Roddy Walsh 🇪🇺 🇺🇦
@roddywalsh.bsky.social
Scientist researching genetics/genomics of heritable heart diseases 🧬🫀 | Liberal extremist | Ex-traveller 🌍 | LFC ⚽️ & Munster 🏉 | He/him
A weekend of 10th anniversaries! Sorry to miss the party for St George's MSc Genomic Medicine. But an amazing meeting for the birthday of the Institute for Cardiomyopathies Heidelberg - great speakers, excellent science and a beautiful location.
October 11, 2025 at 3:34 PM
September 27, 2025 at 11:05 PM
IEVs can co-occur with rare Mendelian pathogenic variants, where they cause a severe phenotype including ⬆️ MACE, or in isolation where they have milder effects (age at diagnosis and wall thickness between genotype-positive and genotype-negative cases).
August 29, 2025 at 4:46 PM
Comparing >10K HCM cases with ancestry-matched controls, we identified 14 IEVs occurring in 6% of cases. Importantly, in 2/3 of carriers, IEVs were in non-sarcomere genes.

While we focused on Euro-ancestry cases, gnomAD data can highlight variants more prevalent in other populations:
August 29, 2025 at 4:46 PM
Champions 😎
April 27, 2025 at 6:22 PM
I was getting a bit irritated by ChatGPT increasingly hallucinating people when asked for peer reviewer suggestions. But I'm not sure its sarcastic response was necessary 😒
March 26, 2025 at 8:21 PM
Regarding monoallelic variants, we did not see an enrichment in UK Biobank analysis, but did see a nominal association with measures of LV hypertrophy. What explains this? The association is clearer to see in populations with high carrier rate? Or other factors?

www.nature.com/articles/s44...
February 14, 2025 at 2:44 PM
This high prevalence of biallelic cases was partially expected based on carrier data in gnomAD (especially p.Gln247* -> Ashkenazi MAF=0.008), but the authors also describe a novel variant (p.Gln93*) with a high MAF of 0.017 in Libyan Jews.

www.nature.com/articles/s44...
February 14, 2025 at 2:44 PM
Interesting case study of a homozygous PLN variant (p.L39*) in a patient with severe DCM requiring HTx (het parents had LV hypertrophy). onlinelibrary.wiley.com/doi/10.1111/... Just the third such case reported (AFAIK) - PLN has very complex geno-pheno associations... #cardiogen #cardiosky 🧬
December 16, 2024 at 5:23 PM
A little editorial I wrote for #JACCHF on the challenges of identifying modifier genetic factors for hypertrophic cardiomyopathy. @jaccjournals.bsky.social authors.elsevier.com/a/1kCHM7tD%7... (<- free access link until Jan 21st) #cardiogen
December 2, 2024 at 9:05 PM
This RE5 variant is found in 4% of Thai BrS cases (case-control OR=45) but absent in >75k non-Thai Asian genomes. Carriers had severe arrhythmic phenotypes, therefore identification and clinical management of carriers is critical to reduce the burden of sudden death in Thailand.
December 21, 2023 at 3:00 PM
To validate its effect, we used CRISPR-Cas9 to introduce the heterozygous variant into hiPSCs. In hiPSC-derived cardiomyocytes, it reduced allele-specific SCN5A expression and caused a 30% reduction in sodium current density based on single cell electrophysiology.
December 21, 2023 at 3:00 PM
To explore this, we sequenced genomes of BrS cases and controls from Thailand. In a BrS-enriched haplotype at SCN5A/10A locus, a rare non-coding variant in an SCN5A intronic enhancer (RE5) was deemed likely causal – affects a conserved base & disrupts a Mef2 TF binding site.
December 21, 2023 at 2:59 PM
BrS is several times more prevalent in East/Southeast Asia compared to other regions but relative yield of ultra-rare LoF variants is lower (~5%). An intermediate effect variant, p.Arg965Cys, is found in 6-7% of cases, but other factors underlying this ⬆️ prevalence are unknown.
December 21, 2023 at 2:59 PM
Brugada syndrome (BrS) is a heritable cardiac disease causing sudden death in young adults. LoF coding variants in SCN5A are found in 20% of Euro-ancestry cases and GWAS reveals a strong polygenic component (SNP heritability 0.17-0.34) & several strong loci at SCN5A/10A.
December 21, 2023 at 2:58 PM
The Trouble with Trabeculation: How Genetics Can Help to Unravel a Complex and Controversial Phenotype - new review article, online now at JCTR, which describes the genetic basis of LVNC and the diagnostic utility of genetic testing. link.springer.com/article/10.1...
November 29, 2023 at 7:08 PM
This study highlights the increasing genetic complexity of cardiomyopathies, with many genes likely to represent variations on a semi-dominant mode of inheritance. Understanding the characteristics of each gene-disease relationship is critical for effect clinical application.
October 9, 2023 at 3:57 PM
For this reason, we tested the 18 recessive genes identified by the meta-analysis for monoallelic associations with cardiac phenotypes and traits in the UK Biobank and identified several novel associations, e.g. LMOD2 truncating variants with DCM.
October 9, 2023 at 3:57 PM
However, discrete categorisation of genes into dominant/recessive is over simplistic, with textbook Mendelian definitions often not reflecting clinical reality, e.g. biallelic variants in sarcomeric HCM/DCM genes lead to complex phenotypes depending on gene and variant class.
October 9, 2023 at 3:56 PM
In this study, we performed a meta-analysis of recessive cardiomyopathy reports (triaging >2k papers), identifying 18 genes with robust & replicated association with isolated/primary cardiomyopathy, largely characterised by DCM phenotypes, early disease onset and severe outcomes.
October 9, 2023 at 3:56 PM
Cardiomyopathies are typically inherited in an autosomal dominant manner (when Mendelian-like variants are identified). However, while the number of dominant gene associations has plateaued in recent years, there have been increasing numbers of reported recessive genes.
October 9, 2023 at 3:55 PM